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OBJECTIVES We sought to assess the incidence and determinants of sudden death (SUD) in mitral
regurgitation due to flail leaflet (MR-FL).
BACKGROUND Sudden death is a catastrophic complication of MR-FL. Its incidence and predictability are
undefined.
METHODS The occurrence of SUD was analyzed in 348 patients (age 67 6 12 years) with MR-FL
diagnosed echocardiographically from 1980 through 1994.
RESULTS During a mean follow-up of 48 6 41 months, 99 deaths occurred under medical treatment.
Sudden death occurred in 25 patients, three of whom were resuscitated. The sudden death
rates at five and 10 years were 8.6 6 2% and 18.8 6 4%, respectively, and the linearized rate
was 1.8% per year. By multivariate analysis, the independent baseline predictors of SUD were
New York Heart Association (NYHA) functional class (p 5 0.006), ejection fraction (p 5
0.0001) and atrial fibrillation (p 5 0.059). The yearly linearized rate of sudden death was 1%
in patients in functional class I, 3.1% in class II and 7.8% in classes III and IV. However, of
25 patients who had SUD, at baseline, 10 (40%) were in functional class I, 9 (36%) were in
class II and only 6 (24%) in class III or IV. In five patients (20%), no evidence of risk factors
developed until SUD. In patients with an ejection fraction $60% and sinus rhythm, the
linearized rate of SUD was not different in functional classes I and II (0.8% per year). Surgical
correction of MR (n 5 186) was independently associated with a reduced incidence of SUD
(adjusted hazard ratio [95% confidence interval] 0.29 [0.11 to 0.72], p 5 0.007).
CONCLUSIONS Sudden death is relatively common in patients with MR-FL who are conservatively managed.
Patients with severe symptoms, atrial fibrillation and reduced systolic function are at higher
risk, but notable rates of SUD have been observed without these risk factors. Correction of
MR appears to be associated with a reduced incidence of SUD, warranting early consideration
of surgical repair. (J Am Coll Cardiol 1999;34:2078–85) © 1999 by the American College
of Cardiology
Mitral regurgitation (MR) is a valvular heart disease that is
increasingly observed because of the aging population and
the high prevalence of degenerative lesions in the adult and
elderly age strata (1). Patients with severe MR may remain
asymptomatic (2), and the indications for surgical correction
of MR are not widely agreed on (3). Patients progressing to
severe symptoms (4) or congestive heart failure (2) can be
operated on successfully (5,6), but sudden death (SUD)
leaves no opportunity for review of therapeutic options.
Sudden death is known to occur in patients with mitral valve
disease managed conservatively. It is a rare complication in
patients with isolated mitral valve prolapse (7,8), but it
appears more frequently in patients with mitral regurgi-
tation due to flail leaflet (MR-FL) (9) or severe MR of
any cause (10). However, the incidence of SUD may be
underrecognized clinically if no systematic inquiry is
made of patients lost to follow-up, and SUD has been the
focus of few reports (8,11), despite its devastating con-
sequences. A notable incidence of SUD in patients with
See page 2086
severe MR, in particular, those cases not preceded by severe
symptoms, would be an incentive for early suppression of
the left ventricular (LV) volume overload due to MR by
performing an early operation (12). Therefore, it is essential
to analyze the incidence, correlates and predictability of
SUD in patients with conservatively managed MR. For this
purpose, the clinical course of patients with MR-FL, who
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invariably have a large degree of MR on the basis of their
valvular lesion (13), allows characterization of the contem-
porary natural history of severe MR (2).
Accordingly, we studied a cohort of patients with
MR-FL diagnosed by echocardiography to 1) determine the
incidence of SUD; 2) define the clinical and echocardio-
graphic features of those who died suddenly; and 3) identify
predictors and effects of treatment on this catastrophic
event.
METHODS
Patients first diagnosed to have flail mitral leaflets on
two-dimensional echocardiography between January 1,
1980 and December 31, 1994 at the Mayo Clinic were
potential candidates for inclusion in the study. Patients were
included in the present study if they did not undergo
surgical correction within one month after diagnosis of
MR-FL. Exclusion criteria were 1) papillary muscle rupture;
2) previous valve surgery; 3) associated moderate or severe
mitral stenosis or aortic valve disease; and 4) coexistent
congenital heart disease. Patients who subsequently were
identified to have coronary artery disease (CAD) or under-
went coronary artery bypass grafting with valvular surgery
were not excluded.
Baseline clinical data were obtained from medical records,
and follow-up was obtained through clinical records, postal
survey and telephone calls to patients and their relatives and
physicians. The mode of terminal events was corroborated
by telephone calls to the patients’ relatives and physicians
and by examination of death certificates and autopsy
records. Death was classified according to the criteria of
Hinkle and Thaler (14), and SUD was inferred if it occurred
within 1 h in a patient who was well or medically stable.
Medications used during follow-up were recorded if pre-
scribed for at least three months. Concomitant medical
illnesses that could potentially affect survival were assigned
weights and summated as a modified comorbidity index
(15).
A comprehensive two-dimensional echocardiographic
study was performed. The diagnosis of flail leaflets was
based on failure of leaflet coaptation, with systolic eversion
of the flail segment into the left atrium (LA) (16). The
severity of MR was assessed semiquantitatively in patients
who had Doppler echocardiography (17). Left ventricular
and LA dimensions were obtained by using M-mode
echocardiography guided with two-dimensional imaging.
Ejection fraction (EF) was visually estimated in all patients
(18) and combined with calculated values (19) in 76% of
patients, as previously reported (20,21), and was used
unaltered from the original echocardiographic report by
means of electronic transfer.
Statistical analysis. Continuous variables are expressed as
the mean value 6 SD or median values and categoric data
as percentages. Group comparisons were performed with
the standard Student t test or chi-square test, as appropriate.
After echocardiographic diagnosis, the rates of all-cause,
cardiac and noncardiac mortality and SUD were estimated
by the Kaplan-Meier method. Analysis was performed, with
censure at the time of mitral valve surgery if this was
eventually performed. Identification of baseline predictors
of SUD was accomplished initially by performing univariate
Cox proportional hazards analysis on candidate clinical,
laboratory and echocardiographic variables. To confirm
independent predictive value, variables with p , 0.10 were
then tested in a multivariate model. To determine the
impact of events occurring during follow-up (congestive
heart failure or surgery) on SUD, time-dependent propor-
tional hazards analyses were performed within multivariate
models, including baseline variables predictive of SUD. To
analyze the effect of surgery on SUD, the events and
follow-up after the operation were accounted for. A value
p , 0.05 was considered significant.
RESULTS
Baseline characteristics. From a cohort of 468 patients
with MR-FL diagnosed by echocardiography from 1980
through 1994, 348 patients (age 67 6 12 years, 74% male)
met eligibility criteria. The cause of flail leaflet was idio-
pathic in 286 patients, endocarditis in 55, traumatic in 5 and
miscellaneous in 2. The posterior leaflet was involved in 297
patients, the anterior leaflet in 45 and both in 6. At
presentation, 214 patients (61%) were in New York Heart
Association (NYHA) functional class I, 85 (24%) were in
class II, 38 (11%) were in class III and 10 (3%) were in class
IV. The functional class could not be determined in one
patient. Among the 48 patients initially in functional class
III or IV, 19 ultimately underwent the operation, 7 were not
candidates for surgery, 7 refused and the others improved
with medical treatment. The LV systolic and diastolic
diameters and EF were 19 6 4 and 33 6 6 mm/m2 and
63 6 10%, respectively. The LA diameter was 28 6
6 mm/m2. Among the 317 patients in whom the degree of
MR was graded by Doppler echocardiography, 259 (82%)
had grade 31 or 41/41 regurgitation.
SUD rates. Follow-up was complete for 345 patients
(99%) up to 1998 or until death. During a mean medical
follow-up of 48 6 41 months, 99 deaths occurred. Sudden
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death occurred in 25 patients under conservative manage-
ment, three of whom collapsed and were successfully resus-
citated. Among those resuscitated, two died after the
operation and one refused the operation and died six
months later. In 10 patients, the cardiac rhythm during the
episode of circulatory collapse could be ascertained—
ventricular fibrillation in seven and ventricular tachycardia
in three. Among the 25 patients with SUD, seven had a
history of possible CAD. Among the other 18 patients,
autopsy in one and angiography in three demonstrated an
absence of coronary occlusive disease, exercise testing was
negative in five and none of the others had signs suggestive
of CAD. Ventricular tachycardia or frequent ventricular
extrasystole on Holter monitoring was noted in six of the
eight patients in whom it was performed. Only one of the
25 patients was treated using class I antiarrhythmic drugs.
The other baseline descriptors of the patients with SUD are
listed in Table 1. Of the other 323 patients, nonsudden
cardiovascular deaths occurred in 49 and noncardiovascular
deaths in 27. At 5 and 10 years, total mortality rates were
29 6 3% and 53 6 5%, respectively; cardiac death rates were
21 6 3% and 43 6 5%; and SUD rates were 8.6 6 2% and
18.8 6 4% (Fig. 1). The yearly linearized rate of SUD was
1.8% (95% confidence interval [CI] 1.2 to 2.6). The mean
time to SUD was 44 6 31 months.
Determinants of SUD. For descriptive purposes, the base-
line characteristics of the patients with SUD (group I)
during follow-up are presented in Table 1, along with those
of patients who had nonsudden cardiovascular deaths
(group II) or noncardiovascular deaths (group III) and those
of patients who survived with conservative management
(group IV). Multiple differences were noted between the
groups. Using univariate Cox proportional hazards analysis,
the baseline predictors of SUD were functional class (p 5
0.0001), atrial fibrillation (p 5 0.001), history of CAD (p 5
0.001), smoking history (p 5 0.03) and creatinine plasma
levels (p 5 0.02). Echocardiographic univariate predictors
were EF (p 5 0.0001), LV end-systolic diameter (p 5
0.002) and LA dimension (p 5 0.002).
By multivariate analysis, baseline independent predictors
of SUD were functional class (p 5 0.006), EF (p 5 0.0001)
and atrial fibrillation (p 5 0.059). The adjusted hazard
ratios associated with these predictors of SUD are indicated
in Table 2. Congestive heart failure developing in the course
of medical surveillance, used as a time-dependent variable,
was associated with SUD in univariate (p 5 0.0001) and
multivariate (p 5 0.0001) analyses.
Predictability of SUD. The yearly rates of SUD according
to baseline functional class are 1.0% in class I, 3.1% in class
Table 1. Baseline Characteristics According to Outcome*
Group
I—SD
(n 5 25)
Group
II—NSCD
(n 5 49)
Group
III—NCD
(n 5 27)
Group
IV—SURV
(n 5 247) p Value†
Age (years) 71 6 9 80 6 8‡ 77 6 10‡ 64 6 11‡ 0.0001
Male gender 21 (84%) 26 (53%)‡ 20 (74%) 189 (77%) 0.004
NYHA functional class III–IV 6 (24%) 17 (35%) 5 (19%) 20 (8%)‡ 0.001
Atrial fibrillation 9 (36%) 19 (39%) 4 (15%) 34 (14%)‡ 0.001
Hypertension 7 (28%) 16 (33%) 9 (33%) 66 (27%) 0.80
Comorbidity index 0.92 6 0.9 0.92 6 0.8 1.30 6 0.9 0.66 6 0.8 0.009
Smoking 14 (56%) 16 (33%) 9 (33%) 105 (43%) 0.23
Serum creatinine (mg/dl) 1.5 6 0.8 1.7 6 2 1.7 6 1.8 1.1 6 0.6 0.002
Total cholesterol (mg/dl) 194 6 45 188 6 60 196 6 51 209 6 45‡ 0.022
LDL cholesterol (mg/dl) 126 6 50 128 6 46 130 6 61 137 6 39 0.27
Ejection fraction (%) 57 6 14 60 6 14 63 6 8 65 6 8‡ 0.0001
LVS diameter (mm/m2) 22 6 5 20 6 4 20 6 5 19 6 4‡ 0.01
LVD diameter (mm/m2) 34 6 5 33 6 5 33 6 6 32 6 6 0.15
LA diameter (mm/m2) 30 6 5 32 6 8 28 6 6 27 6 7‡ 0.0001
*Continuous variables are expressed as the mean value 6 SD and categorical variables as the number of patients (percentage). †Applies to analysis of variance comparison of four
groups. ‡p , 0.05 vs. group I.
LA 5 left atrial; LDL 5 low density lipoprotein; LVD and LVS 5 left ventricular end-diastolic and end-systolic; NCD 5 noncardiac death; NYHA 5 New York Heart
Association; NSCD 5 nonsudden cardiac death; SD 5 sudden death; SURV 5 survivors.
Figure 1. Incidence of total mortality, cardiac mortality and
sudden death in patients with MR-FL. The event rates 6 SEE at
10 years are indicated.
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II and 7.8% in class III or IV (p , 0.0001) (Fig. 2).
However, of the 25 patients with SUD, 10 were in func-
tional class I at diagnosis, 9 were in class II, 5 were in class
III and only 1 was in class IV. Among the 19 patients in
class I or II at baseline, 10 (five in each class) had worsening
of symptoms before SUD. These patients did not undergo
surgery because the symptoms improved rapidly with treat-
ment and were not considered disabling. The rate of SUD
was higher in functional class II than in class I (p , 0.01).
However, this difference was confined to patients with
either atrial fibrillation or EF ,60% (p 5 0.002). When
only patients in sinus rhythm and EF $60% were consid-
ered, yearly rates of SUD in patients in functional class II
and I were not different (0.5% and 0.9%, respectively; p 5
0.60; average 0.8%). The linearized rate of SUD in patients
in functional class I or II, in sinus rhythm, with EF $60%
and with no history of CAD was also 0.8% per year.
The yearly linearized rates of SUD in patients with a
baseline EF ,50% were 12.7%, 0.9% for an EF 50% to 59%
and 1.5% for an EF $60% (p , 0.0001) (Fig. 3). Among
the 25 patients with SUD, EF at diagnosis was $60% in 17
(68%), 50% to 59% in 2 (8%) and ,50% in 6 (24%).
Echocardiography, repeated in five patients within six
months of SUD, showed a decrease of EF under 60% in
only one patient, whereas EF was confirmed .60% in three
and ,50% in one patient. Of the 19 patients in functional
class I or II who had SUD, 15 had an EF $60% (eight in
class I and seven in class II).
The yearly linearized rates of SUD in patients in sinus
rhythm was 1.3%, whereas it was 4.9% in patients with atrial
fibrillation at diagnosis (p 5 0.0004) (Fig. 4). Among the 25
patients with SUD, 16 (64%) were in sinus rhythm at
baseline and 13 remained so until SUD.
Overall, five patients who experienced SUD (20%) pre-
sented no evidence at any time during their follow-up of
atrial fibrillation, LV dysfunction or severe symptoms, until
SUD.
Associated treatment—SUD. No significant differences
were detected comparing the medical treatment during
follow-up of group I versus group II or III with respect to
angiotensin-converting enzyme inhibitors, calcium channel
blockers, beta-blockers, digoxin, hydralazine, class I antiar-
rhythmic agents, diuretics or nitrates (all p . 0.10). How-
ever, when compared with survivors, group I patients were
more often taking digoxin (68% vs. 43%; p 5 0.008),
diuretics (80% vs. 28%; p 5 0.001), calcium channel
blockers (28% vs. 11%; p 5 0.001) and nitrates (16% vs. 5%;
p 5 0.03) and were less often taking beta-blockers (4% vs.
17%; p 5 0.09).
In patients who underwent the operation, SUD occurred
postoperatively in seven, leading to a total number of 32
SUDs in the cohort. In a multivariate proportional hazards
analysis that included the significant predictors of SUD,
surgery performed at any time (time-dependent variable)
independently and favorably influenced the incidence of
unexpected death (adjusted hazard ratio 0.29 [95% CI 0.11
to 0.72], p 5 0.007). This effect persisted when the entire
cohort (n 5 468) was analyzed (p 5 0.0001) and when the
Table 2. Multivariate Predictor of Sudden Death*
Unit Risk Ratio 95% CI p Value
EF (%) Per percent 0.94 0.91–0.97 0.0001
NYHA functional class Per class 1.91 1.20–3.04 0.006
AF Per AF present 2.40 0.97–5.95 0.059
*There were 347 patients in the model.
AF 5 atrial fibrillation; CI 5 confidence interval; EF 5 ejection fraction; NYHA 5 New York Heart Association.
Figure 2. Relation between New York Heart Association
(NYHA) functional class at baseline and sudden death. Left,
Yearly rates of sudden death (6SEE) according to functional
classes I, II and III or IV. Right, Number of sudden death events
according to functional classes I, II and III or IV.
Figure 3. Relation between left ventricular ejection fraction
(LVEF) at baseline and sudden death. Left, Yearly rates of sudden
death (6SEE) according to LVEF classified as $60%, 50% to
59% and ,50%. Right, Number of sudden death events according
to LVEF classified as $60%, 50% to 59% and ,50%.
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occurrence of heart failure during follow-up was included in
the model (p 5 0.01).
DISCUSSION
To our knowledge, the present study reports the largest
series of MR-FL and analyzes the outcome during conser-
vative and postsurgical outcome. It showed that 1) SUD is
a common terminal event in MR, occurring at a linearized
rate of 1.8% per year and accounts for one-fourth of all
deaths under conservative management; 2) risk factors for
SUD can be defined—namely, more severe symptoms, LV
dysfunction and atrial fibrillation; 3) in the absence of risk
factors, a notable yearly rate of SUD of 0.8% is nevertheless
observed; and 4) surgical correction of MR is associated
with a reduced incidence of SUD in patients with MR-FL.
SUD in MR. Sudden death is a major issue in the
management of patients with MR. The frequency and
dismal outcome of LV dysfunction resulting from the
overload due to MR (20,22) have been the basis for
advocating early operation (12). There is no wide agreement
on the indications for surgery in asymptomatic patients
without signs of LV dysfunction (3,23). When a conserva-
tive approach is selected, it is possible to proceed with
surgery when severe symptoms occur, unless SUD prevents
therapeutic intervention (10). Therefore, analyzing the in-
cidence and predictability of SUD in patients with MR is a
central argument in the rationale for early operation.
An association between SUD and mitral valve disease has
been recognized in pathologic studies (9,24,25) and has
been variably assessed in clinical studies (7,10,11,26–28).
Attention has focused principally on mitral valve prolapse
rather than on MR per se, because of the limitations of the
methods of assessment of the degree of MR. However, the
reported incidence of SUD in mitral valve prolapse has been
highly variable (7,29). One major source of confusion
concerns the definition of mitral valve prolapse, which has
been inconsistent (30–32). Thus, mitral valve prolapse in
these previous studies encompassed very different condi-
tions, from morphologically normal but superiorly displaced
leaflets to thick myxomatous valves or flail leaflets with
severe MR (7,27). As echocardiographic criteria for identi-
fying mitral prolapse have evolved (33,34), the definition of
the populations at risk in older studies is questionable and
represents a limitation in the estimation of the risk of SUD.
More recent data suggest that a higher degree of regurgi-
tation in mitral valve prolapse is an important determinant
of the incidence of SUD (27,35,36) and that LV volume
overload is associated with a high recurrence rate of ven-
tricular tachyarrhythmias (37).
Sudden death has been observed in the course of conser-
vative management of severe MR (10,26). However, most
clinical series reporting outcome of patients with MR
observed small numbers of SUDs (10,26,27,35,36). In the
largest series yet reported, 11 cases of SUD accounted for
60% of all cardiovascular deaths (10). However, this series
included patients with ischemic MR. Therefore, the rate of
SUD in severe organic MR has not been established. In the
present study, in the context of uniformly pure organic MR
of large degree (13), the rate of SUD of 1.8% per year was
noteworthy in patients who were mostly asymptomatic and
had little comorbidity. This rate results in approximately
one-fourth of the total mortality with conservative manage-
ment. Remarkably, the hazard of sudden death per year is
approximately equivalent to the operative risk of valve repair
(5,38). Therefore, it is essential to examine the predictability
of this catastrophic complication.
Factors predisposing to SUD. In all patients in whom
cardiac rhythm has been documented during an episode of
SUD, the underlying substrate for SUD was ventricular
tachyarrhythmia. Several reports have documented the prev-
alence of high grade ventricular arrhythmia in mitral valve
prolapse and have inferred a causal role in SUD (27,39–43).
It has been speculated that abnormal traction on papillary
muscles results in arrhythmia that may culminate in SUD
(7,8,44). Complex ventricular arrhythmias have also been
documented in patients with isolated MR (26,45). The
importance and predictive value of ventricular ectopy lead-
ing to SUD have been disputed (46–48) and may be a
surrogate for reduced LV function (11,26). In our cohort,
ventricular arrhythmias were documented in 6 (75%) of 8
patients who underwent Holter monitoring before SUD,
but these arrhythmias were frequent in matched control
subjects (49), in population-based studies (50) and in
patients with valvular heart disease (51). In the absence of
systematic recordings of these arrhythmias with a control
group for objective comparison, causality must be consid-
ered tentative. The role of heart rate variability in the
prediction of SUD deserves analysis in future studies (52).
In the present study, the presence of symptoms was a
significant predictor of SUD in multivariate analysis. In the
presence of severe symptoms, the yearly rate of SUD was
considerable at 7.8%. However, most patients who subse-
quently died suddenly had no or minimal symptoms at
Figure 4. Relation between cardiac rhythm (sinus rhythm or atrial
fibrillation) at baseline and sudden death. Left, Yearly rates of
sudden death (6SEE) in patients in sinus rhythm and atrial
fibrillation. Right, Number of sudden death events observed in
patients in sinus rhythm and atrial fibrillation.
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presentation (10,26). Another important issue is that al-
though patients in functional class II experienced overall a
higher rate of SUD than did those in class I, a similar yearly
rate of SUD between these classes was noted in the absence
of other risk factors. Therefore, the risk of SUD does not
justify, in and by itself, making a stringent distinction
between functional class II and I. In 10 of the 19 patients
who presented with no or minimal symptoms, an episode of
heart failure occurred before SUD. However, these patients
did not have an operation because of rapid clinical improve-
ment with medical therapy. Therefore, symptomatic pro-
gression may not always be a sufficient warning sign.
Another predictor of SUD is reduced LV systolic function,
mostly if it is markedly reduced with an EF ,50% (26).
Notwithstanding, most patients who died suddenly also had
a baseline EF $60% (10). Therefore, in patients with
MR-FL or possibly MR due to other causes (10), SUD can
occur in those who have no or few symptoms and no sign of
LV dysfunction. Similarly, the predictive value of atrial
fibrillation, although significant, is low. Therefore, the
occurrence of this catastrophic event at a yearly rate of 0.8%
in patients who are apparently doing well is important to
take into account in the management strategy of patients
with MR.
Clinical implications. The major question raised by the
relatively high incidence of SUD in patients with MR-FL
conservatively managed is whether this should lead to the
recommendation of early operation even in those without
severe symptoms or signs of LV dysfunction (3,23). In the
absence of a randomized study, it is uncertain that early
mitral valve surgery will reduce or nullify the risk of sudden
cardiac death.
However, there are several arguments in favor of a role for
surgery. Surgery, in the present study, was independently
associated with a reduced risk of SUD (p 5 0.007). Patients
with mild MR tended to display low rates of SUD
(7,29,53), whereas those with mostly severe regurgitation
incurred excess mortality and SUD (2,10). These data
suggest that the degree of LV volume overload that can be
corrected surgically (20) is a determinant of overall and
sudden mortality. Furthermore, the abnormalities of auto-
nomic tone resulting from LV volume overload may be a
predisposing factor to lethal arrhythmia (52,54), and sup-
pressing the LV volume overload surgically results in a
marked decrease in the frequency of complex ventricular
arrhythmia (51). Moreover, early operation in patients with
MR-FL is associated with a marked decrease in overall, and
particularly cardiac, mortality (12). Finally, by minimizing
the occurrence of atrial fibrillation (55), operating may also
tend to prevent SUD.
Another important issue is that despite a large study
group, which allowed the present study to have sufficient
power to assess predictors of SUD, from a clinical point of
view, a large proportion of patients who died suddenly were
minimally symptomatic, were in sinus rhythm and had an
EF .60%. Therefore, individual, clinically meaningful pre-
diction of SUD is limited. A symptomatic progression is an
essential warning sign and should lead to prompt consider-
ation of surgery (2), but because of rapid improvement with
modern treatments, it is not always taken seriously.
Therefore, in our opinion, the risk of SUD with conser-
vative management, roughly equivalent over one year to the
operative risk, is one of the incentives for early operation
and should be an important part of the discussion with
patients when therapeutic options are considered. In future
studies, the potential protective effect of surgery should be
evaluated in appropriately sized prospective studies.
Study limitations. The causal link between valvular heart
disease and SUD is difficult to establish. The contribution of
occult CAD to the rate of SUD (14) cannot be dismissed;
however, in most patients who died suddenly, no ischemic
cardiac symptoms and no evidence of CAD were noted on
invasive or stress tests. Autopsy studies have confirmed that
SUD may occur in patients with MR without CAD (25,56).
Importantly, the rate of SUD in our cohort is at least twice
that observed in a similar age strata in population-based
studies (0.37% per year) (57), suggesting that indeed
MR-FL is linked to the observed mortality.
Antiarrhythmic medications have a proarrhythmic effect
(58), which may contribute to SUD. However, only one
SUD occurred in a patient treated long term with quinidine.
Patients who died suddenly received less therapy with
beta-blockers than did the survivors. These medications
appear to have important protective effects (59), but the
determination of the potential benefit of treatment will
require appropriately sized clinical trials.
Conclusions. The present study of a large cohort of pa-
tients with MR-FL followed conservatively shows that
SUD is relatively frequent, at 1.8% per year, and represents
approximately one-fourth of the causes of death. In patients
with no or minimal symptoms, sinus rhythm and normal
LV function, a linearized rate of 0.8% per year is observed.
Surgery is associated with a reduced incidence of SUD.
Therefore, the risk of operating should be balanced against
the likelihood of other complications of severe MR, in
particular the risk of SUD. It is an additional concern that
this complication of devastating consequence may occur in
patients in sinus rhythm without symptoms or signs of LV
dysfunction, and in our opinion, supports the concept of
early operation.
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